ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRY ARS PHARMACEUTICALS INC

盘后交易 05-10 17:43:28 EDT

8.74

-0.06

-0.68%

盘后8.74

+0.000.00%

16:02 EDT

最高9.00	最低8.59	成交量30.59万
今开8.93	昨收8.80	日振幅4.66%
总市值8.47亿	流通市值3.26亿	总股本9,689万
成交额267.20万	换手率0.82%	流通股本3,729万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRY","market":"US","secType":"STK","nameCN":"ARS PHARMACEUTICALS INC","latestPrice":8.74,"timestamp":1715371200000,"preClose":8.8,"halted":0,"volume":305934,"hourTrading":{"tag":"盘后","latestPrice":8.74,"preClose":8.74,"latestTime":"16:02 EDT","volume":8197,"amount":71641.78,"timestamp":1715371344926},"delay":0,"floatShares":37289303,"shares":96894394,"eps":-0.570969,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.06,"latestTime":"05-10 17:43:28 EDT","open":8.93,"high":9,"low":8.59,"amount":2672031.992043,"amplitude":0.046591,"askPrice":8.84,"askSize":250,"bidPrice":8.5,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.570969,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1715385600000},"adr":0,"listingDate":1607058000000,"adjPreClose":8.8,"preHourTrading":{"tag":"盘前","latestPrice":9.14,"preClose":8.8,"latestTime":"08:47 EDT","volume":100,"amount":914,"timestamp":1715345245173},"postHourTrading":{"tag":"盘后","latestPrice":8.74,"preClose":8.74,"latestTime":"16:02 EDT","volume":8197,"amount":71641.78,"timestamp":1715371344926},"volumeRatio":0.794858},"requestUrl":"/m/hq/s/SPRY","defaultTab":"news","newsList":[{"id":"2434830336","title":"ARS Pharmaceuticals Inc   预计每股亏损13美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434830336","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434830336?lang=zh_cn&edition=full","pubTime":"2024-05-10 19:43","pubTimestamp":1715341420,"startTime":"0","endTime":"0","summary":"   * ARS Pharmaceuticals Inc    预计将在8月8日公布截至2024年6月30日的季度业绩(估计)，季度收入将有所增长。* LSEG 分析师对 ARS 制药公司的平均预期是每股亏损 13 美分。* 华尔街对 ARS Pharmaceuticals Inc 的 12 个月目标价中位数为 19.00 美元，高于其最新收盘价 8.80 美元。5月10日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432502563","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.29%报9.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432502563","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432502563?lang=zh_cn&edition=full","pubTime":"2024-05-01 23:04","pubTimestamp":1714575863,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日23时04分，Ars Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.29%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Cytomx Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1255.88%、167.99%、40.19%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、66.20%、54.57%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012304237a57dd55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012304237a57dd55&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430054292","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大涨5.19%报8.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430054292","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430054292?lang=zh_cn&edition=full","pubTime":"2024-04-26 22:12","pubTimestamp":1714140777,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日22时12分，Ars Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.19%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为975.06%、96.37%、32.79%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Tevogen Bio Holdings Inc.，振幅分别为73.12%、66.85%、30.07%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262212577923fdbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404262212577923fdbd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430128560","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大跌6.90%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430128560","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430128560?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:36","pubTimestamp":1714052189,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时36分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速下挫6.90%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为786.98%、182.46%、6.74%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Processa Pharmaceuticals, Inc.、凯信远达，振幅分别为40.85%、23.46%、14.75%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521362987e83b14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521362987e83b14&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429011630","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.06%报8.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429011630","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429011630?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:39","pubTimestamp":1713883146,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时39分，Ars Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.06%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.55%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Nkgen Biotech Inc C/Wts 31/05/2028、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为2326.94%、174.75%、34.21%，振幅较大的相关个股有Palisade Bio, Inc.、Moolec Science Sa C/Wts 、Immunitybio, Inc.，振幅分别为45.43%、38.82%、27.32%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在全新候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232239077a54f172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232239077a54f172&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426197952","title":"Ars Pharmaceuticals, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426197952","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426197952?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:44","pubTimestamp":1712670263,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日21时44分，Ars Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.04%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Acrivon Therapeutics, Inc.、Biophytis、Mymd Pharmaceuticals, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为344.54%、87.97%、40.57%，振幅较大的相关个股有Biophytis、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Mymd Pharmaceuticals, Inc.，振幅分别为24.30%、19.66%、18.68%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc 是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在一流候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409214423791f6b24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409214423791f6b24&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422612657","title":"Ars Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422612657","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422612657?lang=zh_cn&edition=full","pubTime":"2024-03-26 22:42","pubTimestamp":1711464133,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日22时42分，Ars Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.04%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Nutriband Inc C/Wts 、Stoke Therapeutics, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 涨幅较大，Abvc Biopharma, Inc.、Altamira Therapeutics Ltd.、Stoke Therapeutics, Inc.较为活跃，换手率分别为210.44%、29.26%、28.91%，振幅较大的相关个股有Nutriband Inc C/Wts 、Stoke Therapeutics, Inc.、Mesoblast Ltd，振幅分别为130.19%、34.92%、32.27%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc 是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在一流候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326224213861e1452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326224213861e1452&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422364543","title":"Ars Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报9.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422364543","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422364543?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:55","pubTimestamp":1711374927,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时55分，Ars Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.09%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Xtl生物制药涨幅较大，Altamira Therapeutics Ltd.、Xtl生物制药、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1926.79%、116.87%、57.87%，振幅较大的相关个股有Xtl生物制药、Altamira Therapeutics Ltd.、Brainstorm Cell Therapeutics Inc.，振幅分别为71.37%、47.40%、26.61%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc 是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在一流候选产品 neffy。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521552787e7b7d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032521552787e7b7d1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417411047","title":"Ars Pharmaceuticals, Inc.盘中异动 快速上涨5.32%报9.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417411047","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417411047?lang=zh_cn&edition=full","pubTime":"2024-03-05 22:32","pubTimestamp":1709649137,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日22时32分，Ars Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.32%。Ars Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Ars Pharmaceuticals, Inc.公司简介：ARS Pharmaceuticals Inc 是一家生物制药公司，专注于开发用于紧急治疗 I 型过敏反应的新型、潜在一流候选产品 neffy。消息层面，截至22时32分，Ars Pharmaceuticals, Inc.股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305223217875466ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240305223217875466ce&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ars-pharma.com","stockEarnings":[{"period":"1week","weight":-0.0698},{"period":"1month","weight":-0.0568},{"period":"3month","weight":0.2429},{"period":"6month","weight":1.3592},{"period":"1year","weight":0.9469},{"period":"ytd","weight":0.6058}],"compareEarnings":[{"period":"1week","weight":0.03},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0378},{"period":"6month","weight":0.1806},{"period":"1year","weight":0.2599},{"period":"ytd","weight":0.0944}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ARS Pharmaceuticals, Inc.于2016年1月4日根据特拉华州法律成立。ARS是一家生物制药公司，专注于开发新型的、可能是一流产品的候选产品neffy（以前称为ARS-1），用于I型过敏反应的紧急治疗，包括过敏反应。neffy是一种肾上腺素的专利组合物，带有一种名为Intravail的创新吸收增强剂，可以让neffy在小剂量、易于携带、易于使用、快速给药和可靠的鼻喷雾剂中，以低剂量提供类似注射的肾上腺素吸收。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.09589},{"month":2,"riseRate":0.75,"avgChangeRate":0.156334},{"month":3,"riseRate":0.25,"avgChangeRate":-0.081262},{"month":4,"riseRate":0,"avgChangeRate":-0.132409},{"month":5,"riseRate":0.75,"avgChangeRate":0.015855},{"month":6,"riseRate":0.666667,"avgChangeRate":0.099864},{"month":7,"riseRate":0.666667,"avgChangeRate":0.098083},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.084853},{"month":9,"riseRate":0,"avgChangeRate":-0.347544},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.004265},{"month":11,"riseRate":0.333333,"avgChangeRate":0.055847},{"month":12,"riseRate":0.666667,"avgChangeRate":0.151109}],"exchange":"NASDAQ","name":"ARS PHARMACEUTICALS INC","nameEN":"ARS PHARMACEUTICALS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ARS PHARMACEUTICALS INC(SPRY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ARS PHARMACEUTICALS INC,SPRY,ARS PHARMACEUTICALS INC股票,ARS PHARMACEUTICALS INC股票老虎,ARS PHARMACEUTICALS INC股票老虎国际,ARS PHARMACEUTICALS INC行情,ARS PHARMACEUTICALS INC股票行情,ARS PHARMACEUTICALS INC股价,ARS PHARMACEUTICALS INC股市,ARS PHARMACEUTICALS INC股票价格,ARS PHARMACEUTICALS INC股票交易,ARS PHARMACEUTICALS INC股票购买,ARS PHARMACEUTICALS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ARS PHARMACEUTICALS INC(SPRY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ARS PHARMACEUTICALS INC(SPRY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况